Abstract
TCR affinity for peptide MHC dictates the functional efficiency of T cells and their propensity to differentiate into effectors and form memory. However, in the context of chronic infections, it is unclear what the overall profile of TCR affinity for Ag is and if it differs from acute infections. Using the comprehensive affinity analysis provided by the two-dimensional micropipette adhesion frequency assay and the common indirect affinity evaluation methods of MHC class II tetramer and functional avidity, we tracked IAb GP61–80–specific cells in the mouse model of acute (Armstrong) and chronic (clone 13) lymphocytic choriomeningitis virus infection. In each response, we show CD4 T cell population affinity peaks at the effector phase and declines with memory. Of interest, the range and average relative two-dimensional affinity was equivalent between acute and chronic infection, indicating chronic Ag exposure did not skew TCR affinity. In contrast, functional and tetramer avidity measurements revealed divergent results and lacked a consistent correlation with TCR affinity. Our findings highlight that the immune system maintains a diverse range in TCR affinity even under the pressures of chronic Ag stimulation.
This article is featured in In This Issue, p.3
Footnotes
This work was supported by National Institutes of Health Grants R01 NS071518 and R01 AI096879 and National Institutes of Health Training Grant T32 AI007610 (to B.D.E.).
The online version of this article contains supplemental material.
Abbreviations used in this article:
- ARM
- Armstrong
- B6
- C57BL/6
- CL13
- clone 13
- 2D
- two-dimensional
- 2D-MP
- two-dimensional micropipette adhesion frequency assay
- FSC-A
- forward scatter-area
- hRBC
- human RBC
- LCMV
- lymphocytic choriomeningitis virus
- MFI
- mean fluorescence intensity
- pMHC
- peptide MHC
- pMHC II
- peptide MHC class II
- SPR
- surface plasmon resonance
- WT
- wild type.
- Received February 27, 2018.
- Accepted April 30, 2018.
- Copyright © 2018 by The American Association of Immunologists, Inc.